Suraksha Diagnostic Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
SURAKSHA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts less than Nifty Microcap 250 and 2.5 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Suraksha Diagnostic Limited has submitted its financial results to the NSE for the period ended March 31, 2025. The filing indicates a regulatory disclosure of the company's quarterly or annual financial performance. Specific financial figures such as revenue, profit, margins, or auditor's remarks were not included in the announcement headline. Investors should refer to the detailed financial results document for key numbers and analyst commentary.
This is a routine regulatory filing and by itself does not signal a positive or negative change for shareholders. The actual impact on the stock will depend on the revenue, profit growth, and margin trends shown in the detailed results.